NCT02928692

Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium

Minocycline Attenuate Postoperative Cognitive Dysfunction and Delirium: A Multicenter, Randomized, Double-Blind Clinical Trail

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 750 (estimated)
• Sponsor: RenJi Hospital · Academic / Other
• Sex: All
• Age: 65 Years
• Healthy volunteers: Accepted

Summary

Postoperative cognitive dysfunction (POCD) and postoperative delirium occurs mainly in aged patients. POCD and POD may increase the mortality and morbidity. However, the mechanism of POCD is not clear yet and no effective therapy method was proved. According to previous study, the neuroinflammation is the main reason both for POCD and POD. Minocycline is a tetracycline derivative. Due to it's lipophilic structure, it is easy to pass through blood brain barrier and attenuate neuroinflammation. It's neuroprotective effects has been proven in many experimental animal models such as Alzheimer's disease, Huntington's disease and Parkinson's syndrome. In present study, the investigators hypothesized that minocycline would attenuate the incidence of POCD and POD in the aged patients.

Conditions

• Prostate Cancer
• Carcinoma of the Rectum
• Colon Cancer
• Renal Carcinoma

Interventions

Type	Name	Description
DRUG	Minocycline
DRUG	Placebo

Timeline

• Start date: 2016-11-01
• Primary completion: 2021-12-01
• Completion: 2021-12-01
• First posted: 2016-10-10
• Last updated: 2020-01-28

Locations

5 sites across 1 country: China